$4.24
1.0834.18%
At close: -
$3.66
-0.58-13.68%
After Hours: Jun 20, 7:24 PM EDT
Comments
Loading...
Insight Molecular Analyst Ratings and Price Targets | NASDAQ:IMDX | Benzinga
Insight Molecular Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Insight Molecular Corp from these most-recent analyst ratings.
Analyst Ratings for Insight Molecular
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Insight Molecular (IMDX) stock?
There is no price target for Insight Molecular
What is the most recent analyst rating for Insight Molecular (IMDX)?
There is no analyst for Insight Molecular
When was the last upgrade for Insight Molecular (IMDX)?
There is no last upgrade for Insight Molecular
When was the last downgrade for Insight Molecular (IMDX)?
There is no last downgrade for Insight Molecular.
When is the next analyst rating going to be posted or updated for Insight Molecular (IMDX)?
There is no next analyst rating for Insight Molecular.
Is the Analyst Rating Insight Molecular (IMDX) correct?
There is no next analyst rating for Insight Molecular.
Browse analyst ratings and price targets on all stocks.
